Press release
United States Cardiac Biomarkers Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Novus Biologicals, Fine Biotech Co., Ltd., Labome, Vitrosens Biyoteknoloji, and Real-Gene Labs
Cardiac Biomarkers Market - DataM Intelligence
DataM Intelligence has published a new research report on "Cardiac Biomarkers Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cardiac-biomarkers-market?sg
Key Players: Roche Diagnostics Limited, Abbott, Siemens Healthineers AG, Thermo Fisher Scientific Inc., AdvaCare Pharma, Novus Biologicals, Fine Biotech Co., Ltd., Labome, Vitrosens Biyoteknoloji, and Real-Gene Labs.
USA - Industry Latest News:
✅ 03-Jan-2025 - Abbott: FDA cleared the i-STAT hs-TnI cartridge (point-of-care high-sensitivity troponin I). Abbott announced the 510(k) clearance and said the cartridge would be available in the U.S. on 31-Mar-2025.
✅ 24-Apr-2025 - CardioOne acquires CardioDiagnostics: CardioOne announced it acquired CardioDiagnostics to expand virtual cardiac care and monitoring offerings (acquisition targeted at cardiac/remote diagnostics tech).
✅ 01-Jan-2025 - Cardio Diagnostics / CMS pricing: Cardio Diagnostics reported preliminary CMS (Medicare) pricing determinations for its AI-driven cardiovascular tests (PrecisionCHD / Epi+Gen) - important for U.S. reimbursement & commercialization.
Japan - Industry Latest News:
✅ 10-Jun-2025 - Cardio Diagnostics: Japanese patent granted for AI-driven cardiovascular detection technology (epigenetic/genetic marker interpretation). (Patent/presser coverage shows the company securing IP protection in Japan - enables local commercialization/partnerships).
Korea (South Korea) - Industry Latest News:
✅ mid-2025 (reported 2025) - KAMIR registry update: Korea Acute Myocardial Infarction Registry (KAMIR) reported cumulative enrollment growth (~87,000 patients by mid-2025). This registry continues to generate real-world data that informs biomarker use, validation and local guideline decisions in Korea.
✅ 09-Apr-2025 / July 2025 (events noted in 2025) - Seegene (Korea) - unveiled new diagnostics platforms (CURECATM, STAgoraTM) at conferences in 2025 (demonstrations at ADLM/ADLM-linked events). While not a cardiac-biomarker reagent launch, Seegene's diagnostics automation and analytics activity is a notable Korean diagnostic industry development that can affect assay deployment and lab workflows supporting biomarker testing.
Europe - Industry Latest News:
✅ 30-Sep-2025 - Roche: announced data/press material about a next-generation troponin test (Roche sixth-generation Troponin T) - a notable product development in high-sensitivity troponin assays in Europe (and globally). (date is late-Sep-2025; included because it's a 2025 product update from a major European diagnostics player).
✅ 2025 (company activity) - Siemens Healthineers (corporate developments): in 2025 Siemens / Siemens Healthineers had notable corporate finance activity (stake sales, strategic moves) and the company continued investments in diagnostics production capacity - these corporate moves influence European diagnostics capacity and distribution for cardiac biomarkers.
Growth Forecast Projected:
The Global Cardiac Biomarkers Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Cardiac Biomarkers Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cardiac-biomarkers-market?sg
Key Segments:
By Cardiac Biomarker Tests (Troponin, Creatine kinase, Myoglobin, Galectin-3 and Other)
By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Angina and Other)
By Testing Location (Laboratory Testing, Point of Care Testing)
By Region (North America, Europe, Asia-Pacific, South America and the Middle East & Africa)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Cardiac Biomarkers producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Cardiac Biomarkers revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cardiac-biomarkers-market?sg
FAQ's
Q1: What is the current size of the Cardiac Biomarkers Market?
A: The Cardiac Biomarkers Market stood at US$ 22.25 Billion in 2024 and is set to experience remarkable growth, reaching US$ 67.53 Billion by 2033
Q2: How fast is the Cardiac Biomarkers Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 13.2% from 2025-2033.
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/cardiac-biomarkers-market?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Cardiac Biomarkers Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Novus Biologicals, Fine Biotech Co., Ltd., Labome, Vitrosens Biyoteknoloji, and Real-Gene Labs here
News-ID: 4245205 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Allergic Rhinitis Treatment Market 2025: Industry Developments, Fu …
Allergic Rhinitis Treatment Market is expected to grow at a CAGR of 6.9% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Allergic Rhinitis Treatment Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the…
Eye Health Supplements Market to Grow at 6.8% CAGR, Reaching USD 3.9 Billion by …
The global Eye Health Supplements Market reached USD 2.3 billion in 2024 and is projected to reach USD 3.9 billion by 2032, growing at a CAGR of 6.8% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Bausch + Lomb launched a new AREDS2-based supplement with enhanced lutein and zeaxanthin levels for macular health.
✅ In October 2025, the FDA approved new health…
United States Respiratory Devices Market 2025: Industry Developments, Future Gro …
The Respiratory Devices Market reached US$ 23.45 billion in 2024 and is projected to reach US$ 49.90 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Respiratory Devices Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The…
United States Prostate Cancer Market 2025: Industry Developments, Future Growth, …
Prostate Cancer Market is projected to grow from US$ 13.22 billion in 2024 to US$ 28.10 billion by 2033, registering a CAGR of 7.8% during the forecast period.
DataM Intelligence has published a new research report on "Prostate Cancer Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
